By Acting FDA Commissioner Ned Sharpless, M.D. and Douglas Throckmorton, M.D., Deputy Center Director for Regulatory Programs in FDA's Center for Drug Evaluation and Research
Date:2019-06-03 Views:362
By Acting FDA Commissioner Ned Sharpless, M.D. and Douglas Throckmorton, M.D., Deputy Center Director for Regulatory Programs in FDA's Center for Drug Evaluation and Research
